Drug prices come under fire as US pharma lobby nears spending records
More ambitious changes may be needed to lower pharmaceutical prices as the Trump administration proposes new rules and approves a slew of new generic drugs.
List view / Grid view
News
Regular infusions of a novel antibody may suppress HIV for four months
According to a new report, regular infusions of an antibody that blocks the HIV binding site on human immune cells may have suppressed levels of HIV for up to four months in people undergoing a short-term pause in their antiretroviral therapy (ART) regimens.
Biotechpharma to expand process development and GMP manufacturing capacity to 5,000 L
Biotechpharma UAB will expand its existing manufacturing facility by adding a new line of bioreactors
Europe-Africa partnership spearheads development of next-generation antimalarial drug
The grant will support African trials of a novel antimalarial combination comprising KAF156 (ganaplacide) and lumefantrine in a new once-daily formulation...
Further advances in cell-based influenza vaccine technology announced
An influenza vaccine manufacturer has announced it is filing an Annual Strain Update with the US Food and Drug Administration (FDA) in the coming weeks due to advances in influenza vaccine technology.
EMA restricts use of multiple sclerosis medicine, Lemtrada
Following reports of immune-mediated conditions and problems with the heart and blood vessels (including fatal cases), the EMA (European Medicines Agency) has started a review of the multiple sclerosis medicine, Lemtrada.
Japanese pharma market set for strong growth in 2019
The report, published from CPhI Japan 2019, highlights the country as the second fastest growing mature market for solid dose drugs.
FDA identifies hundreds of devices affected by sterilisation facility closures
FDA has launched a notification system where device manufacturers and users may notify the agency of any shortages or related supply issues stemming from sterilisation facility shutdowns...
ESMO drives EU-level action to tackle shortages of essential medicines
Shortages of inexpensive, essential medicines: calling for tangible political commitments in the EU...
Big pharma blamed for skyrocketing US drug prices
Executives blamed high drug prices on the drugmakers and their pursuit of profits...
Merck recognised with INTERPHEX Exhibitor Award for Best New Product
Merck wins award for first-of-its-kind, single-use tangential flow filtration capsule used in ADC and monoclonal antibody bioprocessing...
Continuous wet granulation manufacturing collaboration
The new facility, built as part of a project called PROSPECT CP, will include blending and feeding of raw materials, twin screw wet granulation, drying and ultimately tabletting...
GSK named one of ‘top companies’ to work for in UK
Some of the key findings show that job seekers are drawn to companies with long histories and large organisations with over 50,000 employees...
Heart drugs free from carcinogens identified as recalls drag on
The Food and Drug Administration has released a list of 40 drugs used to treat hypertension and heart failure that don’t contain any known carcinogens...
Brexit will have ‘minimal’ impact on R&D, expert says
Jonathan Sheffield, OBE, was presenting at the PING (Pharmaceutical Industry Network Group) Brexit Conference 2019 in Hertfordshire, UK...
